Line Plot from Scientific Research

Survival curves of days until likely infection, with animals from antibody treatment groups clustered according to whether they received treatment with the fully neutralizing ITS103.01 mAb (+ITS103.01 mAb) or lacked ITS103.01 in the delivered mAbs (ITS103.01 mAb). Group 1 (control) animals are shown separately. In d and e , survival curves for the control and each mAb treatment group or cluster were compared using a two-tailed Wilcoxon test; significant differences ( P < 0.05, Bonferroni-corrected for multiple comparisons) are indicated for each mAb treatment (by legend colour) versus control.

DOI